Phase 2CompletedAge-related condition
A Biomarker Study of ATH434 in Participants With MSA
An Open-Label Biomarker Study of ATH434 in Multiple System Atrophy
- Sponsor
- Alterity Therapeutics (Industry)
- Enrollment
- 10 enrolled
- Conditions
- Multiple System Atrophy
- Interventions
- ATH434
- Ages
- adults, older adults
- Registry
- NCT05864365
Full record on ClinicalTrials.gov
From the registry
This study will assess the safety and efficacy of ATH434 in participants with a clinical diagnosis of Multiple System Atrophy
Primary outcomes
- Change in brain volume as measured by MRI
History
Last registry update
Primary completion
Started
Registered